#Shingles

A new international study has found that adults over 50 who receive the shingles vaccine can dramatically reduce their risk of major cardiovascular events—including stroke, heart failure, and heart disease—by as much as 23% for up to eight years following vaccination. The findings, published in the European Heart Journal in early May and quickly covered by global outlets such as the European Society of Cardiology and Science Daily, mark a significant turning point for public health, suggesting that the benefits of the vaccine extend far beyond protection against the painful rash caused by herpes zoster.